The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2026

Filed:

Mar. 01, 2021
Applicant:

Aic246 Ag & Co. KG, Wuppertal, DE;

Inventors:

Helmut Buschmann, Aachen, DE;

Thomas Goldner, Velbert, DE;

Jessica Redmer, Monchengladbach, DE;

Jordi Carles Ceron Bertran, La Pobla de Montornes, ES;

Andrea Hawe, Munich, DE;

Matthias Lucke, Munich, DE;

Dorothea Hohmann, Hamburg, DE;

Monica Rosa, Munich, DE;

Assignee:

AIC246 AG & Co. KG, Wuppertal, DE;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/517 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 9/10 (2006.01); A61K 9/19 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/40 (2006.01); A61P 31/20 (2006.01); A61P 31/22 (2006.01);
U.S. Cl.
CPC ...
A61K 31/517 (2013.01); A61K 9/19 (2013.01); A61K 47/10 (2013.01); A61K 47/18 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01);
Abstract

The present invention relates to new stable pharmaceutical compositions containing 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid and sodium ions that are essentially free from complexing solubilizing agents, such as PEG, cyclodextrin, lysine, arginine, in particular HPBCD. The invention further relates to methods of preparation of said pharmaceutical compositions. The invention further relates to use of said pharmaceutical compositions in methods of treatment of and/or as a prophylactic for illnesses, particularly its use as an antiviral, preferably against cytomegaloviruses.


Find Patent Forward Citations

Loading…